Download Free Conquering Cancer Volume Two Book in PDF and EPUB Free Download. You can read online Conquering Cancer Volume Two and write the review.

This cancer case report series documents the effectiveness of the nutritional/enzyme cancer treatment designed by Nicholas J. Gonzalez, MD. The book provides an in-depth analysis of the Gonzalez Protocol in both theory and practice, with fifty representative patients with biopsy-proven pancreatic or breast cancer. This pioneering book includes patients diagnosed with a poor prognosis or terminal malignancies who did well under Dr. Gonzalez's care. Conquering Cancer: Volume Two was published in 2017 and includes 19 additional types of cancer. These two volumes of Conquering Cancer are the culmination of Dr. Gonzalez's twenty-eight-year medical career, as he died suddenly and unexpectedly in July 2015. This book is now available to all those with an interest in cancer in general, the enzyme treatment of cancer in particular, alternative medicine, and The Gonzalez Protocol®. Note: this is NOT a "how-to" book for self-treatment.
A companion to Conquering Cancer: Volume One - 50 Pancreatic and Breast Cancer Best Case Reports from Nicholas J. Gonzalez, M.D. This second volume includes 62 patients and 17 different types of cancer on his nutritional enzyme therapy. Including: *Adenoid Cystic Carcinoma*Bladder*Colon*Kidney*Liver*Leukemia*Lung*Lymphoma*Melanoma*Mesothelioma*Ovarian*Prostate*Salivary Gland*Sarcoma*Thyroid*Uterine*Waldenstrom's Macroglobulinemia
This edition originally published: South Yarra, Vic.: Michelle Anderson Publishing, 2013.
When Dr. Elior Kinarthy retired from California to the seaside city of Victoria, British Columbia, he was soon faced with a daunting challenge. Diagnosed with prostate cancer, he began a fifteen-year journey to finding the treatment plan that would save his life. By altering and augmenting advice by his oncologists, he created an anti-cancer lifestyle with alternative medicine and supplements. He eventually discovered the Gorter Model of holistic immunotherapy in Cologne, Germany, and has been cancer-free ever since. Now eighty-three, he offers hope to cancer patients and encourages them to use innovative approaches to treatment as they strengthen their bodies, minds, and spirits and walk toward a brighter, healthier future.
At just 28 years old, and five short months after her 22-year-old sister had been diagnosed with melanoma, Jen Cerminara found herself being told that she, too, had cancer. After digesting the fact that she had Hodgkin’s lymphoma, Jen set out to write the most unconventional cancer book possible. Equipped with plenty of advice, as well as inspiration and lots of laughs, this Jersey girl shows you how to get through the most difficult time of your life with a smile on your face. Laughing in the Storm is designed to inform you of what you might expect during chemotherapy and radiation. Jen knew that to conquer cancer, she needed faith, a positive attitude, and a good sense of humor! Nothing is off limits in this book, including the large tumor in Jen’s chest, her wig, and the horrendous side effects of cancer treatment.
THE AUTHORIZED BIOGRAPHY: When Nick Gonzalez was a medical student, he stood beside his father's deathbed and vowed that he would find a cure for cancer. Nick imagined his future as a researcher toiling away in a lab in Memorial Sloan Kettering, working on conventional approaches to the disease. Yet Gonzalez's life was anything but conventional. At the urging of Linus Pauling, he had already left an accomplished journalism career and entered Cornell Medical School. Gonzalez's path took another turn when he met the controversial Dr. William Kelley, a dentist who, through an alternative nutritional approach, had arrested his own pancreatic cancer. Kelley had become infamous when he'd tried to help others. The Maverick M.D. is the story of how Dr. Nick Gonzalez perfected the scientific theory behind Kelley's work and put the protocol into practice in New York City. Gonzalez drew courage from his Christian faith, from his Mexican-Italian-American family, and from key loved ones, colleagues and mentors. He spent years treating patients with the most serious conditions--from cancer to diabetes to lupus. But he wasn't satisfied as an outlier in the medical community. He wanted his work put to the test with a clinical trial. Gonzalez could have gone to Mexico where his family had lived and set up a cancer clinic alongside other alternative practitioners. Instead, he stayed in New York City, secured the funding, and fought to have his protocol tested through a properly run clinical trial. The Maverick, M.D. dramatizes Nicholas Gonzalez' backstory and his battles with the forces that sought to squelch his research, keeping his healing discoveries in medicine from reaching the world.  This book portrays a man who fought for the acceptance of a nutritional cancer treatment in the halls of some of the most established U.S. medical institutions. Against intense opposition, Nick Gonzalez's determination held up until the end--a scientist who developed a therapy that saves lives and promotes the healing of the human mind, body and spirit.
In 1998, Nicholas Gonzalez, M.D. received National Cancer Institute approval for a clinical trial to evaluate his nutritional-enzyme approach in the treatment of patients with pancreatic cancer. Though Dr. Gonzalez hoped the venture would initiate an era of cooperation between conventional scientists and serious alternative researchers, problems plagued the study from its beginning. The design discouraged patient participation; conventional oncologists discouraged patients from joining and at times pressured those already admitted for nutritional therapy to change to more conventional treatment. Then in 2000 the NCI insisted that all patient selection decisions be turned over to the Principal Investigator, who as it turned out helped develop the chemotherapy protocol used as the control treatment.Repeatedly, the Principal Investigator approved patients for the nutritional treatment who did not meet the entry requirements, or who were too ill or uncommitted to follow the self-administered regimen. An evaluation by government scientists in early 2005 confirmed that so many patients had failed to follow the prescribed nutritional therapy that the data had little meaning. Despite such problems, without Dr. Gonzalez¿ knowledge the Principal Investigator published an article implying the study was properly run, patients complied fully and that the nutritional therapy had no effect.In response, Dr. Gonzalez, a former journalist, has written What Went Wrong, to bring the truth of this project to light, and show how bias, indifference, and at times incompetence undermined a promising research effort that, if properly run, might have ushered in a new direction in cancer treatment.
Conquering RAS: From Biology to Cancer Therapy provides introductory knowledge on how modern RAS biology is taking shape in light of newer technological development. Each chapter is written in a manner that emphasizes simplicity and readability for both new investigators and established researchers. While RAS biology has been intensively studied for more than three decades, we are yet to see any effective therapeutics that could interfere in the signaling cascade regulated by this master oncogene. The book covers topics ranging from basic RAS biology, to translational biology and drug discovery applications. These topics will be appealing to basic researchers working in labs who seek deeper understanding of the modern concepts in RAS research. On the other side, the oncologist at the patient's bedside will find the book useful as they routinely face the daunting task of treating patients that predominantly have a disease driven by oncogenic KRAS. - Brings together wide ranging topics in RAS basic and translational biology for the scientific and clinical communities - Showcases recent advancements in RAS research under one comprehensive volume - Includes video clips, color illustrations, and important website links to facilitate a clear understanding of RAS in cancer research